Undesirable effects and cosmetovigilance after product launch
How to receive, assess, document and report undesirable and serious undesirable effects associated with cosmetic products in the EU.
Read the guide →Complex projects often extend beyond a single document. Specialist support connects formulation, suppliers, laboratories, packaging and commercial timelines in a workable regulatory plan.
Regulatory support for formulation development, reformulation, fragrances, essential oils, testing, packaging, private labels and due diligence.
The exact scope is confirmed after reviewing the product, target markets and available documentation.
EUCRI coordinates the selection of testing and expert interpretation of results; testing itself is entrusted to suitable laboratories.
Yes. The scope is adapted to the allocation of responsibilities between the brand, manufacturer and Responsible Person.
Yes, for an individual product, a portfolio or a project before a commercial decision.
How to receive, assess, document and report undesirable and serious undesirable effects associated with cosmetic products in the EU.
Read the guide →What Regulation (EU) 2023/1545 changes for fragrance allergen labelling, which thresholds apply and how to prepare formulas and labels for 2026 and 2028.
Read the guide →How to plan reformulation after an ingredient restriction and align testing, CPSR, PIF, labelling, CPNP and packaging stocks.
Read the guide →Send us the essential product details, target markets and available documentation. We will respond by email.